The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis. (2017)
Attributed to:
MRC Centre for Regenerative Medicine
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1126/scitranslmed.aaf3962
PubMed Identifier: 28539470
Publication URI: http://europepmc.org/abstract/MED/28539470
Type: Journal Article/Review
Volume: 9
Parent Publication: Science translational medicine
Issue: 391
ISSN: 1946-6234